Paratesticular rhabdomyosarcoma in children.
The clinical characteristics, surgical treatment, clinical grouping, chemotherapy, radiotherapy, complications and survival of paratesticular rhabdomyosarcoma are discussed. When the combined approach of radical inguinal orchiectomy, retroperitoneal node dissection, chemotherapy and radiotherapy when indicated is used a survivorship in excess of 80 per cent can be anticipated for all stages of disease. A combined multidisciplinary approach to this lesion is stressed to achieve improved survivorship in this previously lethal lesion.
D002648:Child; D002675:Child, Preschool; D002699:Chlorambucil / Q000008:administration & dosage; D003609:Dactinomycin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D012208:Rhabdomyosarcoma / Q000150:complications / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery*; D013736:Testicular Neoplasms / Q000150:complications / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery*; D014750:Vincristine / Q000008:administration & dosage
D002699:Chlorambucil; D003609:Dactinomycin; D014750:Vincristine; D004317:Doxorubicin